Nicolas Villain

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 80 publications

Amyloid PET Quantitation and Centiloid Thresholds in the Diagnosis of Alzheimer Disease: An Individual Participant Data Meta-Analysis.

Amyloid PET Quantitation and Centiloid Thresholds in the Diagnosis of Alzheimer Disease: An Individual Participant Data Meta-Analysis.

Journal: JAMA

Published: July 13, 2026

Multilayer brain connectivity and long-term cognitive changes in individuals at risk for Alzheimer's disease.

Multilayer brain connectivity and long-term cognitive changes in individuals at risk for Alzheimer's disease.

Journal: Journal of Alzheimer's disease : JAD

Published: July 01, 2026

PatientSpace: A multimodal graph-based latent representation framework for modeling neurodegenerative disease heterogeneity.

PatientSpace: A multimodal graph-based latent representation framework for modeling neurodegenerative disease heterogeneity.

Journal: NeuroImage

Published: June 03, 2026

White matter hyperintensities in Alzheimer's disease in the era of anti-amyloid therapies.

White matter hyperintensities in Alzheimer's disease in the era of anti-amyloid therapies.

Journal: Alzheimer's & dementia (Amsterdam, Netherlands)

Published: March 30, 2026

Iatrogenic Cerebral Amyloid Angiopathy After Cardiac Surgery: Two Case Reports.

Iatrogenic Cerebral Amyloid Angiopathy After Cardiac Surgery: Two Case Reports.

Journal: Neurology

Published: March 19, 2026

Author Response: The Great Debate in Diagnosing Alzheimer Disease: More Than Just a β Test.

Author Response: The Great Debate in Diagnosing Alzheimer Disease: More Than Just a β Test.

Journal: Neurology

Published: February 20, 2026

Reader Response: Alzheimer Disease Is a Specific Disorder Defined by Neuropathology Detectable During Life.

Reader Response: Alzheimer Disease Is a Specific Disorder Defined by Neuropathology Detectable During Life.

Journal: Neurology

Published: February 20, 2026

Simulated shared and supported decision making for amyloid immunotherapy in Alzheimer's disease: A bicentric study.

Simulated shared and supported decision making for amyloid immunotherapy in Alzheimer's disease: A bicentric study.

Journal: Revue neurologique

Published: December 29, 2025

Defining Alzheimer's disease: stipulations and the ethics of diagnostic change.

Defining Alzheimer's disease: stipulations and the ethics of diagnostic change.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: October 21, 2025

Lecanemab in France: The Times They Are a-Changin'?

Lecanemab in France: The Times They Are a-Changin'?

Journal: Revue neurologique

Published: September 25, 2025

An International Working Group viewpoint on stratifying risk and prevention of the clinical expression of Alzheimer's disease.

An International Working Group viewpoint on stratifying risk and prevention of the clinical expression of Alzheimer's disease.

Journal: Nature aging

Published: September 22, 2025

petBrain: a new pipeline for amyloid, Tau tangles and neurodegeneration quantification using PET and MRI.

petBrain: a new pipeline for amyloid, Tau tangles and neurodegeneration quantification using PET and MRI.

Journal: Alzheimer's research & therapy

Published: June 02, 2025

Showing 1-12 of 80

Last Updated: 09/26/2026